Myalgic encephalomyelitis/chronic fatigue syndrome
We’re all in this for good.
- help each other live better and uncover the best ways to manage your health today
- help researchers shorten the path to new treatments tomorrow
How much good can your data do? A whole lot, as co-founder Jamie Heywood explains in this video.
What is myalgic encephalomyelitis/chronic fatigue syndrome?
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome which may also be known as Systemic exertion intolerance disease is characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer.
Common symptoms reported by people with myalgic encephalomyelitis/chronic fatigue syndrome
Common symptoms
How bad it is
What people are taking for it
Reports may be affected by other conditions and/or medication side effects. We ask about general symptoms (anxious mood, depressed mood, fatigue, pain, and stress) regardless of condition.
Last updated:
Treatments taken by people for myalgic encephalomyelitis/chronic fatigue syndrome
Treatment name(s)
Type
How many have tried
Tried for
Type
Prescription Drug
How many have tried
5206
Tried for
myalgic encephalomyelitis/chronic fatigue syndrome
(27)
Type
Prescription Drug
How many have tried
6135
Tried for
myalgic encephalomyelitis/chronic fatigue syndrome
(15)
Type
Prescription Drug
How many have tried
42
Tried for
myalgic encephalomyelitis/chronic fatigue syndrome
(11)
Data from patients with myalgic encephalomyelitis/chronic fatigue syndrome, who have ever reported treatments, ordered by their reporting frequency during the last 5 years.
Last updated:
Compare treatments taken by people with myalgic encephalomyelitis/chronic fatigue syndrome
Treatment name(s)
Perceived effectiveness
Side effects
Total evaluations
Tried for
Perceived effectiveness
for myalgic encephalomyelitis/chronic fatigue syndrome (16 evaluations)
Total evaluations
20
Tried for
myalgic encephalomyelitis/chronic fatigue syndrome
(27)
Perceived effectiveness
for myalgic encephalomyelitis/chronic fatigue syndrome (4 evaluations)
Total evaluations
13
Tried for
myalgic encephalomyelitis/chronic fatigue syndrome
(15)
Perceived effectiveness
for myalgic encephalomyelitis/chronic fatigue syndrome (6 evaluations)
Total evaluations
6
Tried for
myalgic encephalomyelitis/chronic fatigue syndrome
(11)
- Major
- Moderate
- Slight
- None
- Can't tell
- Severe
- Moderate
- Mild
- None
Data from patients with myalgic encephalomyelitis/chronic fatigue syndrome, who have ever reported treatments, ordered by their reporting frequency during the last 5 years.
Last updated:
Who has myalgic encephalomyelitis/chronic fatigue syndrome on PatientsLikeMe?
- 10 new patients joined this month
- 4198 say ME/CFS is their primary condition
| Age | Proportion | # of patients |
|---|---|---|
| <20 | 19 | |
| 20s | 421 | |
| 30s | 1603 | |
| 40s | 4013 | |
| 50s | 6249 | |
| 60s | 4553 | |
| 70+ | 1382 |
| Age at first symptom | Proportion | # of patients |
|---|---|---|
| 0-19 years | 1103 | |
| 20-29 years | 1475 | |
| 30-39 years | 1841 | |
| 40-49 years | 1425 | |
| 50-59 years | 512 | |
| 60-69 years | 68 | |
| 70+ years | 8 |
Distribution of sex
| Sex | Proportion | # of patients |
|---|---|---|
| Male | 1523 | |
| Female | 16841 |
| Condition Types | Proportion | # of patients |
|---|---|---|
| Chronic fatigue immune dysfunction syndrome (CFIDS) | 649 | |
| Chronic fatigue syndrome (CFS) | 2030 | |
| Myalgic encephalomyelitis (ME) | 1033 | |
| Neuroendocrine immune disorder | 165 | |
| Post-viral fatigue syndrome (PVFS) | 352 | |
| Systemic exertion intolerance disease (SEID) | 52 |
| Diagnosis status | Proportion | # of patients |
|---|---|---|
| Diagnosed | 8442 | |
| Not Diagnosed | 3850 |
These charts show data from ME/CFS patients who have completed their condition history
Last updated: